$300 Billion in Life Sciences Revenue at Risk. The Intelligence Behind It Is Months Old. Behavior Labs Launches a Decision Intelligence Platform That Addresses This Gap.
Behavior Labs, a new life sciences intelligence company, today launched a platform that gives pharmaceutical and medical device teams continuous strategic intelligence — powered by what the company calls a World Model, a continuously operating model of the market reality each product exists in. The platform replaces quarterly review cycles with daily, cross-validated insight across the full product lifecycle, from patent cliff defence and biosimilar war-gaming to regulatory pathway optimisation and post-market surveillance.
